Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001209191-19-030079

Director disposed of 598,935 shares (other)

  • Director acquired 13,413 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Belldegrun Arie · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2019-05-13 Other disposition : show line 1 in the form −598,935 4,791,480 I
2019-05-13 Other acquisition : show line 2 in the form +13,413 515,076 I
Loading xslF345X03/doc4.xml…